BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/9/2021 9:07:56 AM | Browse: 626 | Download: 1292
 |
Received |
|
2020-12-23 16:24 |
|
Peer-Review Started |
|
2020-12-24 13:19 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-02-11 03:30 |
|
Revised |
|
2021-02-14 08:14 |
|
Second Decision |
|
2021-03-17 10:42 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-03-17 15:23 |
|
Articles in Press |
|
2021-03-17 15:23 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-04-02 10:14 |
|
Publish the Manuscript Online |
|
2021-04-09 09:07 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Opinion Review |
| Article Title |
How far along are we in revealing the connection between metformin and colorectal cancer?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Maja Cigrovski Berkovic, Danko Mikulic, Ines Bilic-Curcic and Anna Mrzljak |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Anna Mrzljak, FEBG, MD, PhD, Associate Professor, Department of Medicine, Merkur University Hospital, School of Medicine, Zajčeva 19, Zagreb 10000, Croatia. anna.mrzljak@gmail.com |
| Key Words |
Metformin; Type 2 diabetes mellitus; Colorectal cancer; Chemoprevention; Recurrence-free survival; Surgery |
| Core Tip |
Metformin is one of the oldest oral antidiabetic agents used to treat type 2 diabetes mellitus. While there is substantial evidence that metformin may have a chemopreventive role in colorectal cancer (CRC) development, the data on the possible effects of metformin after surgery and other CRC treatment is much less conclusive. |
| Publish Date |
2021-04-09 09:07 |
| Citation |
Cigrovski Berkovic M, Mikulic D, Bilic-Curcic I, Mrzljak A. How far along are we in revealing the connection between metformin and colorectal cancer? World J Gastroenterol 2021; 27(14): 1362-1368 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i14/1362.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i14.1362 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
